Compare Flowserve Corporation Common Stock (FLS) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flowserve Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Flowserve Corporation Common Stock trades at $72.28 (market cap $8.85B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Flowserve Corporation Common Stock pays a 1.26% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FLS | HALO | |
|---|---|---|
Market Cap | $8.85B | $12.58B |
Volume | 1,955,324 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $92.04 | $115.22 |
52-Week Low | $49.09 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.44B | $14.49B |
Dividend Yield | 1.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Flowserve Corporation Common Stock
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
